Digital PCR and Real-Time PCR Market in 2024 Detailed Study Analysis

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital PCR and Real-Time PCR Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs)- Market Outlook And Industry Analysis 2031"

The global Digital PCR and Real-Time PCR Market Size is valued at 8.29 billion in 2022 and is predicted to reach 16.43 billion by the year 2031 at an 8.02% CAGR during the forecast period for 2023-2031.

Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1772

Digital PCR is an end-point PCR method for absolute quantification and analyzing minority sequences against a backdrop of similar majority sequences. Digital PCR (dPCR) allows for the exact and sensitive measurement of nucleic acids. Traditional PCR is a semi-quantitative end-point assay in which the amplified result is detected using agarose gel electrophoresis. Real-time PCR (or qPCR) employs fluorescence-based detection to allow the accumulation of amplified products to be measured as the reaction advances. Normalization to controls or a standard curve is required for qPCR, which allows only relative quantification. Variations in amplification efficiency may also have an impact on qPCR results. Droplet digital PCR, chip-based digital PCR, and beamed digital PCR are the three primary types of digital PCR (dPCR). The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is driving the growth of the global digital polymerase chain reaction market. The digital PCR test is utilized for molecular cancer diagnostics.

List of Prominent Players in the Digital PCR and Real-Time PCR Market:
• Abbott Laboratories
• Agilent Technologies, Inc.
• Analytik Jena AG
• Becton Dickinson and Company
• Bio Molecular Systems
• Biomeme Inc.
• Biomérieux S.A.
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Cole-Parmer Instrument Company Llc
• Danaher Corporation
• Elitech Group Sas
• Endress+Hauser
• Enzo Life Sciences, Inc.
• Eppendorf AG
• F. Hoffmann-LA Roche Ltd.
• Fluidigm Corporation
• JN Medsys PTE, LTD.
• Merck KGAA
• Meridian Bioscience, Inc.
• Promega Corporation
• Qiagen N.V.
• Quidel Corporation
• Quanta Biosciences Inc.
• Sacace Biotechnologies Srl
• Standard Biotools
• Stilla Technologies
• Takara Bio, Inc.
• Thermo Fisher Scientific, Inc.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1772

Market Dynamics:
Drivers-
Consumer demand for early disease identification and treatment has pushed research and development of novel genetic approaches and product development. Furthermore, more substantial investment and the availability of funds and incentives are boosting R&D activity. Furthermore, governments and federal organizations around the world are emphasizing the significance of qPCR and dPCR technologies in genomics research. Again, in the qPCR and dPCR industries over the last decade, various financing attempts by government and private organizations to help genomic research have been noticed.

Challenges:
Globally, significant inflation in industrialized economies has resulted in an overall price increase over the last two years. The cumulatively deteriorating general purchasing power is projected to have a considerable influence on developing economies and is regarded as beneficial in a variety of ways. The paper examines the impact of high inflation on the global economy's long-term performance and gives information on fiscal policies that measure and mitigate its short-term effects on demand/supply, cash flow, and currency exchange. The Global Digital PCR & Real-Time PCR Market research forecasts substantial inflation, taking into account the influence of cost-push and demand-pull inflation.

Regional Trends:
The North America Digital PCR and Real-Time PCR Market is anticipated to record a significant market share in revenue and is projected to raise at a high CAGR soon. The increased availability of R&D funding for genomic research and the region's robust research infrastructure are driving the expansion of the Digital PCR (dPCR) and Real-Time PCR (qPCR) markets in North America. When compared to other regions, North America is experiencing growth due to the early commercialization of Digital PCR (dPCR) and Real-Time PCR (qPCR) products. Because of increased financing for Digital PCR (dPCR) and Real-Time PCR (qPCR) technologies, the North American region, including Canada and the United Kingdom, is expected to be the largest market. The Asia Pacific region is expected to witness significant growth opportunities due to rapidly developing economies, increased government support for life science research, an aging population associated with an increase in the incidence of genetic diseases, expanding research, and clinical trial out-sourcing from the region, all of which are expected to increase demand for Digital PCR (dPCR) and Real-Time PCR (qPCR) in the region.

Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1772

Recent Developments:
• In October 2022, Roche gained FDA approval to utilize the COVID-19 PCR test on Cobas 6800/8800 systems. One of the first COVID-19 PCR tests conducted on an automated, high-throughput capabilities platform to earn FDA 510(k) clearance is the Cobas SARS-CoV-2 Qualitative test.

Segmentation of Digital PCR and Real-Time PCR Market-
By Product-& Services
• qPCR Product-& Services
o qPCR Reagents and Consumables
o qPCR Instruments
o qPCR Software and Services
• dPCR Product-& Services
o dPCR Reagents and Consumables
o dPCR Instruments
 Chip-based Digital PCR
 Beaming Digital PCR
o dPCR Software and Services)
By Application-
• Clinical Applications
o Infectious Disease Testing
o Oncology Testing
o Blood Screening
o Transplant Diagnostics
o Other Clinical Applications
• Research Applications
• Forensic Applications
• Environmental Applications
• Other Applications
By End-User-
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology
• CROS & CDMOS
• Forensic Laboratories
• Other End-Users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

For More Information: https://www.insightaceanalytic.com/report/digital-pcr-and-real-time-pcr-market/1772

Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118

Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.